PPAR-α Agonist Improves Fat Oxidation in Burned Children
Author Information
Author(s): Melanie G Cree, Bradley R Newcomer, David N Herndon, Ting Qian, Dayoung Sun, Beatrice Morio, Jennifer J Zwetsloot, G Lynis Dohm, Ricki Y Fram, Ronald P Mlcak, Asle Aarsland, Robert R Wolfe
Primary Institution: University of Texas Medical Branch
Hypothesis
Does PPAR-α agonism increase palmitate oxidation and decrease intracellular lipids in pediatric burn trauma patients?
Conclusion
PPAR-α agonist treatment increases palmitate oxidation but does not change intracellular fat concentrations in burn trauma children.
Supporting Evidence
- Insulin sensitivity and palmitate oxidation increased significantly after PPAR-α treatment.
- Mitochondrial palmitate oxidation rates in muscle samples increased significantly after treatment.
- No changes in muscle triglyceride or liver triglyceride concentrations were observed.
Takeaway
This study found that a medication helped kids with burn injuries use fat better for energy, but it didn't change the amount of fat stored in their muscles.
Methodology
A double-blind placebo-controlled trial was conducted with 18 children receiving either PPAR-α agonist or placebo, measuring fat oxidation and insulin sensitivity.
Potential Biases
Potential bias due to the small sample size and the specific population studied (burn trauma children).
Limitations
The study had a small sample size and short treatment duration, which may limit the generalizability of the findings.
Participant Demographics
Children aged 4-17 years with severe burn injuries, primarily Hispanic males.
Statistical Information
P-Value
0.003, 0.004, 0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website